Brown bullhead (Ameiurus nebulosus) skin carcinogenesis.
Alternative models using fish species have been tested in liver toxicity and carcinogenesis bioassays. Similar models have not been developed for skin. The brown bullhead (Ameiurus nebulosus) has shown potential as a model for skin carcinogenesis studies due to its sensitivity to environmental chemical pollutants. The present study is an initial morphologic and biochemical characterization of the normal and neoplastic brown bullhead skin to assess its suitability as a model of skin carcinogenesis. Brown bullhead were removed from Back River in the Chesapeake Bay region, an area historically polluted with heavy metals and polycyclic aromatic hydrocarbons. Histology, histochemistry, and electron microscopy were used to stage the morphologic development and progression of neoplasia in skin. The distribution of keratin, a family of structural proteins with altered expression in mammalian tumorigenesis, was analyzed with one and two dimensional gel electrophoresis and nitrocellulose blots of extracts from normal skin. Keratin expression in skin and other organs was also assessed with immunohistochemistry using AE1, AE3, and PCK 26 antibodies, and the proliferation index in skin and neoplasms with PCNA antibody. Skin lesions appeared to progress from hyperplasia through carcinoma, and the proliferation index was increased in papilloma. Also in papilloma, intercellular interdigitations appeared increased and desmosomes decreased which may in future studies correlate with changes in expression of other molecular markers of neoplastic progression. Both Type I and Type II keratin subfamilies were detected in skin using gel electrophoresis with the complimentary keratin blot-binding assay. For further development of the brown bullhead model, future studies can compare and relate these baseline data to alterations in expression of keratin and other markers in fish neoplasms and to molecular events which occur in man.
Division of Comparative Medicine, Johns Hopkins University, Baltimore USA. Tracie.e.bunton@dupontpharma.com
T E
TE
Bunton
D000818:Animals; D015197:Carcinogenicity Tests; D004591:Electrophoresis, Polyacrylamide Gel; D004848:Epithelium / Q000473:pathology; D005399:Fishes; D006651:Histocytochemistry; D006841:Hydrocarbons, Aromatic / Q000633:toxicity; D006965:Hyperplasia; D007633:Keratins / Q000032:analysis; D008046:Lip; D019216:Metals, Heavy / Q000633:toxicity; D008854:Microscopy, Electron; D010212:Papilloma / Q000473:pathology; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D012878:Skin Neoplasms / Q000139:chemically induced*; D014874:Water Pollutants, Chemical / Q000633:toxicity*
D006841:Hydrocarbons, Aromatic; D019216:Metals, Heavy; D018809:Proliferating Cell Nuclear Antigen; D014874:Water Pollutants, Chemical; D007633:Keratins